Key result
Transfemoral TAVI with ProGlide yields an ~19% vascular complication rate, higher with prolonged procedures.
Why the study?
Vascular complications are commonly observed after transfemoral TAVI, and this study aimed to evaluate their prevalence, predictors, and outcomes.
What are the prevalence, independent predictors, and clinical outcomes of vascular complications in patients undergoing transfemoral TAVI using the ProGlide closure device?
Cohort (n=1,055)
No
What are the prevalence, independent predictors, and clinical outcomes of vascular complications in patients undergoing transfemoral TAVI using the ProGlide closure device?
Answers are grounded in this paper and cite their sources.
In a large real-world transfemoral TAVI cohort using ProGlide closure, major vascular complications were low (3.7%) and did not impact mortality, while right femoral access and 14 Fr sheaths significantly reduced vascular complication risk.
Background. Vascular complications (VCs) are commonly observed after transfemoral transcatheter aortic valve implantation (TAVI) procedures. Closure devices for the access site were developed to reduce their incidence. We aim to evaluate the prevalence, predictors, and outcomes of the occurrence of post-TAVI VCs. Materials and Methods. A retrospective study was conducted on 1336 consecutive patients who underwent TAVI at the University Hospital of Toulouse, France, between January 2016 and March 2020. All included procedures were performed through the common femoral artery, and ProGlide® was the used closure device. The studied population was divided into two groups depending on the occurrence of VCs defined according to Valve Academic Research Consortium-2 criteria. Results. The mean age of the studied population was 84.4 ± 6.9, and 48% were male. 90% of TAVI interventions were performed through the right femoral artery. The prevalence of VCs was 18.8%, and 3.7% were major. Prolonged procedure duration was an independent predictor of VCs. Using the right access site and smaller introducer size (14 Fr) were preventive factors. No significant difference in mortality rate was detected between the two groups. Conclusion. This study showed a low prevalence for post-TAVI VCs, especially for the major type. An increase in bleeding events and prolonged cardiac care unit stay were the common adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Matta et al. (2021) conducted a cohort in Severe aortic stenosis undergoing transfemoral transcatheter aortic valve implantation (TAVI) (n=1,055). Transfemoral TAVI using Perclose ProGlide closure device (with evaluation of post-TAVI vascular complications) vs. Patients without post-TAVI vascular complications (n=856) was evaluated on Post-TAVI vascular complications defined according to Valve Academic Research Consortium-2 (VARC-2) criteria. Transfemoral TAVI with ProGlide closure resulted in an 18.8% overall vascular complication rate, with procedure duration >120 min increasing risk.
Synapse has enriched 10 related papers. Consider them for comparative context: